Pathstone Holdings’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.9K | Hold |
50,650
| – | – | ﹤0.01% | 2120 |
|
|
2025
Q1 | $68.9K | Hold |
50,650
| – | – | ﹤0.01% | 2157 |
|
|
2024
Q4 | $192K | Hold |
50,650
| – | – | ﹤0.01% | 2179 |
|
|
2024
Q3 | $137K | Hold |
50,650
| – | – | ﹤0.01% | 2218 |
|
|
2024
Q2 | $157K | Hold |
50,650
| – | – | ﹤0.01% | 2184 |
|
|
2024
Q1 | $230K | Sell |
50,650
-1
| -0% | -$5 | ﹤0.01% | 2066 |
|
|
2023
Q4 | $348K | Buy |
+50,651
| New | +$348K | ﹤0.01% | 1723 |
|